Toolkit/CBN-loaded soy lecithin liposomes
CBN-loaded soy lecithin liposomes
Also known as: CBN-loaded liposomes, soy lecithin liposomes
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Based on these findings, CBN was selected for formulation into soy lecithin liposomes. The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.
Usefulness & Problems
Why this is useful
This formulation encapsulates cannabinol in soy lecithin liposomes and is presented as an antioxidant delivery system with enhanced diffusion behavior. The abstract reports favorable colloidal properties, increased membrane order, and retained radical scavenging activity.; encapsulation of cannabinol for antioxidant delivery; early-stage dermal formulation development; enhancing diffusion behavior in a semi-solid model
Source:
This formulation encapsulates cannabinol in soy lecithin liposomes and is presented as an antioxidant delivery system with enhanced diffusion behavior. The abstract reports favorable colloidal properties, increased membrane order, and retained radical scavenging activity.
Source:
encapsulation of cannabinol for antioxidant delivery
Source:
early-stage dermal formulation development
Source:
enhancing diffusion behavior in a semi-solid model
Problem solved
It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.; provides a liposomal delivery format for CBN; improves diffusion relative to a control solution in the reported model
Source:
It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.
Source:
provides a liposomal delivery format for CBN
Source:
improves diffusion relative to a control solution in the reported model
Problem links
improves diffusion relative to a control solution in the reported model
LiteratureIt addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.
Source:
It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.
provides a liposomal delivery format for CBN
LiteratureIt addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.
Source:
It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.
Published Workflows
Objective: Identify a cannabinoid with strong antioxidant performance and convert it into a liposomal formulation with favorable physicochemical properties and improved diffusion behavior for dermal antioxidant applications.
Why it works: The workflow first profiles structurally distinct cannabinoids to identify the strongest antioxidant candidate, then formulates the selected compound into liposomes and tests whether key delivery-relevant properties and diffusion behavior are preserved or improved.
Stages
- 1.Analytical profiling of structurally distinct cannabinoids(broad_screen)
This stage identifies which cannabinoid is the strongest antioxidant candidate before committing to formulation work.
Selection: Structural characterization and antioxidant profiling across DPPH, hydroxyl, and superoxide radical scavenging assays.
- 2.Liposomal formulation of the selected cannabinoid(library_build)
This stage converts the selected antioxidant cannabinoid into a delivery format suitable for downstream physicochemical and diffusion testing.
Selection: Formulate the selected antioxidant payload into soy lecithin liposomes.
- 3.Physicochemical and functional characterization of CBN-loaded liposomes(secondary_characterization)
This stage checks whether the liposomal formulation remains physically suitable and functionally active after loading CBN.
Selection: Assess colloidal properties, membrane order, and retained antioxidant activity after encapsulation.
- 4.Diffusion testing in a gelatin-based semi-solid model(confirmatory_validation)
This stage provides an early-stage screen of whether the formulation improves mobility in a model relevant to dermal application goals.
Selection: Use EPR imaging to compare diffusion of liposomal CBN against a control solution in a semi-solid model.
- 5.Decision framing for dermal antioxidant application(decision_gate)
This stage interprets whether the combined data justify positioning the formulation as a promising dermal antioxidant candidate.
Selection: Integrate physicochemical, antioxidant, and diffusion results to assess promise for dermal antioxidant use.
Steps
- 1.Characterize five cannabinoids by MS and NMR
Identify structural features relevant to antioxidant function before selecting a formulation payload.
Structural characterization precedes candidate selection because the study first profiles the tested cannabinoids before choosing one for formulation.
- 2.Measure radical scavenging across DPPH, hydroxyl, and superoxide assays and select CBN
Rank antioxidant performance and choose the lead cannabinoid for formulation.
Selection occurs after profiling because the formulation stage is explicitly based on these antioxidant findings.
- 3.Formulate selected CBN into soy lecithin liposomesengineered formulation
Create a delivery system for the selected antioxidant cannabinoid.
Formulation follows lead selection because only the top antioxidant candidate was advanced into liposomes.
- 4.Measure colloidal size and membrane order of CBN-loaded liposomesformulation under characterization
Assess whether the liposomal formulation has favorable colloidal properties and signs of bilayer stabilization.
Physicochemical characterization is performed after formulation to determine whether the assembled liposomes are suitable for downstream functional testing.
- 5.Test retained antioxidant activity of CBN-loaded liposomes against free CBNformulation under functional comparison
Determine whether encapsulation preserves radical scavenging function.
Functional antioxidant testing follows formulation because the key question is whether encapsulation retains activity relative to the free compound.
- 6.Compare diffusion of liposomal CBN and control solution by EPR imaging in a gelatin semi-solid modelformulation and assay platform
Evaluate whether the liposomal formulation improves mobility in an early-stage dermal-relevant model.
Diffusion testing is done after physicochemical and antioxidant characterization to assess whether a functionally acceptable formulation also shows improved mobility.
- 7.Interpret early-stage diffusion model results with explicit model limitationcandidate formulation and screening model
Decide whether the combined evidence is sufficient to position the formulation as promising for dermal antioxidant use.
This interpretation follows all characterization and diffusion testing so the application claim can be made with stated caveats.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
Functional AssayTarget processes
recombinationInput: Chemical
Implementation Constraints
The reported system requires cannabinol, soy lecithin liposome formulation, antioxidant activity assays, and EPR imaging in a gelatin-based semi-solid model for the described evaluation workflow.; requires formulation of CBN into soy lecithin liposomes; performance evidence is limited in the abstract to physicochemical assays, radical scavenging assays, and a gelatin-based semi-solid diffusion model
The abstract does not show performance in actual skin architecture or in vivo dermal delivery. It also notes a moderate reduction in antioxidant activity relative to free CBN after encapsulation.; moderate reduction in antioxidant activity compared to free CBN; reported diffusion model does not replicate skin architecture
Validation
Supporting Sources
Ranked Claims
CBN-loaded liposomes retained significant radical scavenging activity, but this activity was moderately reduced compared with free CBN.
Antioxidant activity assays showed that CBN-loaded liposomes retain significant radical scavenging capacity, though with a moderate reduction compared to free CBN.
CBN-loaded liposomes are presented as a promising candidate for dermal antioxidant applications because they combine favorable physicochemical properties with enhanced diffusion behavior.
These results position CBN-loaded liposomes as a promising candidate for dermal antioxidant applications, combining favorable physicochemical properties with enhanced diffusion behavior.
The gelatin-based semi-solid EPR diffusion model is cost-effective and reproducible for early-stage mobility screening but does not replicate skin architecture.
While the current model does not replicate skin architecture, it provides a cost-effective and reproducible platform for early-stage screening of formulation mobility.
In a gelatin-based semi-solid model, liposomal CBN showed superior diffusion compared with the control solution by EPR imaging.
EPR imaging further demonstrated superior diffusion of liposomal CBN through a gelatin-based semi-solid model compared to the control solution.
Increased membrane order after CBN incorporation suggests enhanced stability of the liposomal bilayer.
Results indicating increased membrane order upon CBN incorporation suggest enhanced stability of the liposomal bilayer.
CBN-loaded soy lecithin liposomes had favorable colloidal properties with an average size of about 122.9 ± 0.4 nm.
The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.
Approval Evidence
Based on these findings, CBN was selected for formulation into soy lecithin liposomes. The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.
Source:
CBN-loaded liposomes retained significant radical scavenging activity, but this activity was moderately reduced compared with free CBN.
Antioxidant activity assays showed that CBN-loaded liposomes retain significant radical scavenging capacity, though with a moderate reduction compared to free CBN.
Source:
CBN-loaded liposomes are presented as a promising candidate for dermal antioxidant applications because they combine favorable physicochemical properties with enhanced diffusion behavior.
These results position CBN-loaded liposomes as a promising candidate for dermal antioxidant applications, combining favorable physicochemical properties with enhanced diffusion behavior.
Source:
In a gelatin-based semi-solid model, liposomal CBN showed superior diffusion compared with the control solution by EPR imaging.
EPR imaging further demonstrated superior diffusion of liposomal CBN through a gelatin-based semi-solid model compared to the control solution.
Source:
Increased membrane order after CBN incorporation suggests enhanced stability of the liposomal bilayer.
Results indicating increased membrane order upon CBN incorporation suggest enhanced stability of the liposomal bilayer.
Source:
CBN-loaded soy lecithin liposomes had favorable colloidal properties with an average size of about 122.9 ± 0.4 nm.
The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts the liposomal formulation with free CBN and a control solution in diffusion testing. It also compares CBN against four other structurally distinct cannabinoids during the initial antioxidant profiling stage.
Source:
The abstract contrasts the liposomal formulation with free CBN and a control solution in diffusion testing. It also compares CBN against four other structurally distinct cannabinoids during the initial antioxidant profiling stage.
Source-backed strengths
favorable colloidal properties; increased membrane order suggesting enhanced bilayer stability; retains significant radical scavenging capacity after encapsulation; superior diffusion through a gelatin-based semi-solid model versus control solution
Source:
favorable colloidal properties
Source:
increased membrane order suggesting enhanced bilayer stability
Source:
retains significant radical scavenging capacity after encapsulation
Source:
superior diffusion through a gelatin-based semi-solid model versus control solution
Compared with cdiGEBS
CBN-loaded soy lecithin liposomes and cdiGEBS address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical
Compared with H-2Kb-ADSCs
CBN-loaded soy lecithin liposomes and H-2Kb-ADSCs address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical
Compared with orthoflavivirus pseudovirus technology
CBN-loaded soy lecithin liposomes and orthoflavivirus pseudovirus technology address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical
Ranked Citations
- 1.